Targeting Bcl-2/Bcl-XL induces antitumor activity in uveal melanoma patient-derived xenografts.

por Fariba Némati, Catherine de Montrion, Guillaume Lang, Laurence Kraus-Berthier, Guillaume Carita, Xavier Sastre-Garau, Aurélie Berniard, David Vallerand, Olivier Geneste, Ludmilla de Plater, Alain Pierré, Brian Lockhart, Laurence Desjardins, Sophie Piperno-Neumann, Stéphane Depil, Didier Decaudin
Publicado 2014